3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street

707
Comment
2

3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street

Motley Fool2022-09-22

KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

707

Report

Comment

LEESIMON
·2022-09-23
‌[爱心] ‌Great
Reply
Like
Report
K74
·2022-09-23
Alright
Reply
1
Report
Fold Replies
- K74:
  Miss opportunity
  2022-09-23
  Reply
  Report
- K74:
  To
  2022-09-23
  Reply
  Report
- K74:
  Okay
  2022-09-23
  Reply
  Report
View more 2 comments
Looyusooi
·2022-09-23
0k
Reply
Like
Report
Sphere
·2022-09-23
Yeap. Full faith
Reply
2
Report
Fold Replies
- Sphere:
  Up
  2022-09-23
  Reply
  Report
Jess261
·2022-09-23
Okay
Reply
1
Report
TANJH
·2022-09-23
Ok
Reply
4
Report
SSVC
·2022-09-23
K
Reply
3
Report
Fold Replies
- JackTL:
  kk
  2022-09-23
  Reply
  Report
ericbqlee
·2022-09-23
🙂
Reply
5
Report
tigernaut
·2022-09-23
👍
Reply
3
Report
Llim
·2022-09-23
Like
Reply
4
Report
Fold Replies
- TANJH:
  ok
  2022-09-23
  Reply
  Report
- twm124:
  ok
  2022-09-23
  Reply
  Report
runningjames
·2022-09-23
Let's wait and see...
Reply
3
Report
Fold Replies
- SimonChan:
  👍🏻
  2022-09-23
  Reply
  Report
Ghostwalker
·2022-09-23
Good
Reply
2
Report
Sorrie2u
·2022-09-23
$Tesla Motors(TSLA)$
Reply
2
Report
Fold Replies
- DWWM:
  👍🏻
  2022-09-23
  Reply
  Report
SPOT_ON
·2022-09-23
Skip
Reply
2
Report
Fold Replies
- JCWOO:
  Ok
  2022-09-23
  Reply
  Report
- ramius75:
  👍
  2022-09-23
  Reply
  Report
xiaobaii
·2022-09-23
like & comment
Reply
3
Report
Fold Replies
- tungleh:
  Done
  2022-09-23
  Reply
  Report
Born to Thrive
·2022-09-23
Ok thanks
Reply
3
Report
Fold Replies
- aden53:
  ok
  2022-09-23
  Reply
  Report
- BG68:
  sure no kidding
  2022-09-23
  Reply
  Report
Alkid
·2022-09-23
Okay
Reply
4
Report
Fold Replies
- xiaobaii:
  like & comment
  2022-09-23
  Reply
  Report
- Alkid:
  K
  2022-09-23
  Reply
  Report
FrankieTok
·2022-09-23
Ok
Reply
3
Report
JeJu
·2022-09-23
Ok
Reply
3
Report
JeJu
·2022-09-23
Ok
Reply
5
Report
Fold Replies
- JeJu:
  Ok
  2022-09-23
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1168375426?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-09-22 23:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168375426","market":"us","top_or_hot":-1,"title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","media":"Motley Fool","content":"<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","article_id":"1168375426","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","pubTimestamp":1663860442,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc.","META":"Meta Platforms","NVDA":"英伟达"},"translate_title":"据华尔街报道，三只跌停的股票可能会从52周低点飙升51%至70%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"META":0.9,"MRNA":0.9,"NVDA":0.9},"content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9913393566,"gmtCreate":1663905360855,"gmtModify":1676537361040,"author":{"id":"3579044609497336","authorId":"3579044609497336","name":"LEESIMON","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":9,"crmLevelSwitch":1},"htmlText":"‌<a href=\"\">[爱心]&nbsp;</a>‌Great","listText":"‌<a href=\"\">[爱心]&nbsp;</a>‌Great","text":"‌[爱心] ‌Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913393566","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9913992688,"gmtCreate":1663894274544,"gmtModify":1676537357572,"author":{"id":"3574026189533561","authorId":"3574026189533561","name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Alright&nbsp;","listText":"Alright&nbsp;","text":"Alright","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":17,"repostSize":0,"link":"https://ttm.financial/post/9913992688","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104050755,"gmtCreate":1663894426053,"gmtModify":1663894430499,"authorId":3574026189533561,"author":{"id":3574026189533561,"authorId":3574026189533561,"name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913992688,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Miss opportunity</span>","text":"<span class=\"s1\">Miss opportunity</span>","html":"<span class=\"s1\">Miss opportunity</span>"},{"id":104050751,"gmtCreate":1663894412546,"gmtModify":1663894415722,"authorId":3574026189533561,"author":{"id":3574026189533561,"authorId":3574026189533561,"name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913992688,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">To</span>","text":"<span class=\"s1\">To</span>","html":"<span class=\"s1\">To</span>"},{"id":104050749,"gmtCreate":1663894401724,"gmtModify":1663894405296,"authorId":3574026189533561,"author":{"id":3574026189533561,"authorId":3574026189533561,"name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913992688,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Okay</span>","text":"<span class=\"s1\">Okay</span>","html":"<span class=\"s1\">Okay</span>"},{"id":104050745,"gmtCreate":1663894394226,"gmtModify":1663894398073,"authorId":3574026189533561,"author":{"id":3574026189533561,"authorId":3574026189533561,"name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913992688,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Bagholder</span>","text":"<span class=\"s1\">Bagholder</span>","html":"<span class=\"s1\">Bagholder</span>"},{"id":104050742,"gmtCreate":1663894384495,"gmtModify":1663894387887,"authorId":3574026189533561,"author":{"id":3574026189533561,"authorId":3574026189533561,"name":"K74","avatar":"https://community-static.tradeup.com/news/0915c1dbb625a1fab842a01a98e9f31a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913992688,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Be</span>","text":"<span class=\"s1\">Be</span>","html":"<span class=\"s1\">Be</span>"}],"langContent":"EN"},{"id":9913057785,"gmtCreate":1663891439148,"gmtModify":1676537356379,"author":{"id":"4100437715079400","authorId":"4100437715079400","name":"Looyusooi","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"0k","listText":"0k","text":"0k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913057785","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9913064327,"gmtCreate":1663890199469,"gmtModify":1676537355780,"author":{"id":"3573432013960035","authorId":"3573432013960035","name":"Sphere","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":0},"htmlText":"Yeap. Full faith","listText":"Yeap. Full faith","text":"Yeap. Full faith","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9913064327","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104049300,"gmtCreate":1663890205590,"gmtModify":1663890209091,"authorId":3573432013960035,"author":{"id":3573432013960035,"authorId":3573432013960035,"name":"Sphere","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913064327,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Up</span>","text":"<span class=\"s1\">Up</span>","html":"<span class=\"s1\">Up</span>"}],"langContent":"EN"},{"id":9913069411,"gmtCreate":1663889856134,"gmtModify":1676537355605,"author":{"id":"3586490638953193","authorId":"3586490638953193","name":"Jess261","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913069411","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9913013173,"gmtCreate":1663888475492,"gmtModify":1676537354996,"author":{"id":"3572430244287129","authorId":"3572430244287129","name":"TANJH","avatar":"https://static.tigerbbs.com/08f0a812db3886c7089d529cb706b8fa","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913013173","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9913013976,"gmtCreate":1663888460595,"gmtModify":1676537354988,"author":{"id":"3574906731000207","authorId":"3574906731000207","name":"SSVC","avatar":"https://static.tigerbbs.com/545a5ea462ff4ac7cc100bd3d8d97f72","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9913013976","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104049447,"gmtCreate":1663890686077,"gmtModify":1663890690009,"authorId":3581557493426416,"author":{"id":3581557493426416,"authorId":3581557493426416,"name":"JackTL","avatar":"https://static.tigerbbs.com/851801800e7dc3457e5e60048a987880","vip":1,"currentWearingBadge":{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1102},"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913013976,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">kk</span>","text":"<span class=\"s1\">kk</span>","html":"<span class=\"s1\">kk</span>"}],"langContent":"EN"},{"id":9913038574,"gmtCreate":1663888040598,"gmtModify":1676537354783,"author":{"id":"4101424154342900","authorId":"4101424154342900","name":"ericbqlee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0},"htmlText":"🙂","listText":"🙂","text":"🙂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913038574","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9913004428,"gmtCreate":1663886676665,"gmtModify":1676537354325,"author":{"id":"3567239827558758","authorId":"3567239827558758","name":"tigernaut","avatar":"https://static.tigerbbs.com/66e331c670eb88443b88c6bdb76224cf","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":1},"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913004428","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9913001344,"gmtCreate":1663885861988,"gmtModify":1676537354166,"author":{"id":"4105239963331670","authorId":"4105239963331670","name":"Llim","avatar":"https://community-static.tradeup.com/news/ebdd6aa492c9d80d8a2c1a18334bff87","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9913001344","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104048687,"gmtCreate":1663888486048,"gmtModify":1663888489317,"authorId":3572430244287129,"author":{"id":3572430244287129,"authorId":3572430244287129,"name":"TANJH","avatar":"https://static.tigerbbs.com/08f0a812db3886c7089d529cb706b8fa","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913001344,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":104048263,"gmtCreate":1663886811027,"gmtModify":1663886815443,"authorId":4103447123846720,"author":{"id":4103447123846720,"authorId":4103447123846720,"name":"twm124","avatar":"https://community-static.tradeup.com/news/133c111c9a6cf675442b0a95780a91d0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913001344,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"EN"},{"id":9913001073,"gmtCreate":1663885815392,"gmtModify":1676537354166,"author":{"id":"4117336023184202","authorId":"4117336023184202","name":"runningjames","avatar":"https://community-static.tradeup.com/news/3467c93ce8ec8c583f28f405e68f0c00","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":2,"crmLevelSwitch":1},"htmlText":"Let's wait and see...","listText":"Let's wait and see...","text":"Let's wait and see...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9913001073","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104048529,"gmtCreate":1663888024595,"gmtModify":1663888027778,"authorId":3572212448091017,"author":{"id":3572212448091017,"authorId":3572212448091017,"name":"SimonChan","avatar":"https://static.tigerbbs.com/9becd538a97d2ba19c33053c87e741cf","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9913001073,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍🏻</span>","text":"<span class=\"s1\">👍🏻</span>","html":"<span class=\"s1\">👍🏻</span>"}],"langContent":"EN"},{"id":9913000686,"gmtCreate":1663885525045,"gmtModify":1676537354086,"author":{"id":"4095988560725080","authorId":"4095988560725080","name":"Ghostwalker","avatar":"https://static.tigerbbs.com/23573df57053ba2bfe809c087c7ce4b1","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9913000686","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9919775700,"gmtCreate":1663885217300,"gmtModify":1676537354006,"author":{"id":"3557997848207595","authorId":"3557997848207595","name":"Sorrie2u","avatar":"https://community-static.tradeup.com/news/61cbe83d2927cba11b9b940c52c7e69e","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":1},"htmlText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a><v-v data-views=\"1\"></v-v>","text":"$Tesla Motors(TSLA)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9919775700","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104048455,"gmtCreate":1663887749679,"gmtModify":1663887753064,"authorId":3576740278830885,"author":{"id":3576740278830885,"authorId":3576740278830885,"name":"DWWM","avatar":"https://static.tigerbbs.com/454eae1d592c63bceb83b57c108b3272","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919775700,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍🏻</span>","text":"<span class=\"s1\">👍🏻</span>","html":"<span class=\"s1\">👍🏻</span>"}],"langContent":"EN"},{"id":9919771227,"gmtCreate":1663884800770,"gmtModify":1676537353859,"author":{"id":"3582922989777578","authorId":"3582922989777578","name":"SPOT_ON","avatar":"https://static.tigerbbs.com/080f029371339d9db26930961de6adb1","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1},"htmlText":"Skip","listText":"Skip","text":"Skip","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9919771227","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104049566,"gmtCreate":1663890946796,"gmtModify":1663890950700,"authorId":3555021653927318,"author":{"id":3555021653927318,"authorId":3555021653927318,"name":"JCWOO","avatar":"https://static.tigerbbs.com/9cf6fbc0cc76c16681b5ff2564f07dad","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919771227,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":104048056,"gmtCreate":1663885593886,"gmtModify":1663885597489,"authorId":3586470645934044,"author":{"id":3586470645934044,"authorId":3586470645934044,"name":"ramius75","avatar":"https://community-static.tradeup.com/news/c4c299991e47de2cfc27ff1e679cc5ee","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.14","exceedPercentage":"93.62%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919771227,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">👍</span>","text":"<span class=\"s1\">👍</span>","html":"<span class=\"s1\">👍</span>"}],"langContent":"EN"},{"id":9919770251,"gmtCreate":1663884578273,"gmtModify":1676537353779,"author":{"id":"3571345352614779","authorId":"3571345352614779","name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"like &amp; comment","listText":"like &amp; comment","text":"like & comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9919770251","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104047843,"gmtCreate":1663884896800,"gmtModify":1663884900423,"authorId":3581840130059040,"author":{"id":3581840130059040,"authorId":3581840130059040,"name":"tungleh","avatar":"https://static.itradeup.com/news/e7cd8f0c265e9dabe49dea7b97ffe6b9","vip":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919770251,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":9919746381,"gmtCreate":1663883844043,"gmtModify":1676537353627,"author":{"id":"4088897570389930","authorId":"4088897570389930","name":"Born to Thrive","avatar":"https://community-static.tradeup.com/news/8964f1dd097a81e13db97e05ca201467","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":1,"crmLevelSwitch":1},"htmlText":"Ok thanks&nbsp;","listText":"Ok thanks&nbsp;","text":"Ok thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9919746381","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104047857,"gmtCreate":1663884962393,"gmtModify":1663884965738,"authorId":4094435594173410,"author":{"id":4094435594173410,"authorId":4094435594173410,"name":"aden53","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919746381,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":104047841,"gmtCreate":1663884887331,"gmtModify":1663884897652,"authorId":4106439073723520,"author":{"id":4106439073723520,"authorId":4106439073723520,"name":"BG68","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919746381,"type":1,"supId":0,"prevId":0,"content":"sure no kidding","text":"sure no kidding","html":"sure no kidding"}],"langContent":"EN"},{"id":9919755195,"gmtCreate":1663882508618,"gmtModify":1676537353425,"author":{"id":"3574044380631135","authorId":"3574044380631135","name":"Alkid","avatar":"https://static.tigerbbs.com/d584ca72b32575d58fab92034b2973bc","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9919755195","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104047761,"gmtCreate":1663884587494,"gmtModify":1663884590863,"authorId":3571345352614779,"author":{"id":3571345352614779,"authorId":3571345352614779,"name":"xiaobaii","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919755195,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">like &amp; comment</span>","text":"<span class=\"s1\">like &amp; comment</span>","html":"<span class=\"s1\">like &amp; comment</span>"},{"id":104047523,"gmtCreate":1663882516823,"gmtModify":1663882520351,"authorId":3574044380631135,"author":{"id":3574044380631135,"authorId":3574044380631135,"name":"Alkid","avatar":"https://static.tigerbbs.com/d584ca72b32575d58fab92034b2973bc","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.74%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919755195,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">K</span>","text":"<span class=\"s1\">K</span>","html":"<span class=\"s1\">K</span>"}],"langContent":"EN"},{"id":9919752532,"gmtCreate":1663882403326,"gmtModify":1676537353409,"author":{"id":"3574939514199057","authorId":"3574939514199057","name":"FrankieTok","avatar":"https://static.tigerbbs.com/0b65f73d55f0d11210ac82b597a07550","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9919752532","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9919727412,"gmtCreate":1663879429836,"gmtModify":1676537353065,"author":{"id":"3586678960137089","authorId":"3586678960137089","name":"JeJu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9919727412","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9919727553,"gmtCreate":1663879424472,"gmtModify":1676537353064,"author":{"id":"3586678960137089","authorId":"3586678960137089","name":"JeJu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9919727553","repostId":1168375426,"repostType":4,"repost":{"id":"1168375426","pubTimestamp":1663860442,"share":"https://www.laohu8.com/m/news/1168375426?lang=&edition=full","pubTime":"2022-09-22 23:27","market":"us","language":"en","title":"3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1168375426","media":"Motley Fool","summary":"Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision ","content":"<html><head></head><body><p><b>KEY POINTS</b></p><ul><li>Nvidia plans to launch several new chips that could improve its fortunes.</li><li>Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.</li><li>Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.</li></ul><p>Analysts remain very bullish about these former big winners.</p><p>Down but not out. That old adage applies to many one-time high-flying growth stocks.</p><p>Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.</p><p>1. Nvidia: New chips on the way</p><p><b>Nvidia</b> is a former rising star that&#39;s crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.</p><p>Analysts don&#39;t appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia&#39;s current share price.</p><p>Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.</p><p>Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won&#39;t last forever.</p><p>2. Meta Platforms: A big-tech bargain</p><p>Facebook-parent <b>Meta Platforms</b> hasn&#39;t received many &#34;likes&#34; from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta&#39;s massive and risky investment in the metaverse.</p><p>However, Wall Street remains highly optimistic about Meta&#39;s prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.</p><p>What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta&#39;s shares currently trade at only 12.2 times expected earnings. The company&#39;s social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that&#39;s still very attractive to advertisers.</p><p>A rebound in digital-advertising growth would help Meta meet analysts&#39; expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg&#39;s vision of the metaverse is fulfilled.</p><p>3. Moderna: A potential bull in the China shop</p><p><b>Moderna</b> is yet another company that&#39;s seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It&#39;s now down more than 70% from the peak set in the summer of 2021.</p><p>The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.</p><p>Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.</p><p>Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.</p><p>Over the longer term, Moderna hopes to expand beyond COVID-19. The company&#39;s pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Beaten-Down Stocks That Could Soar 51% to 70% From Their 52-Week Lows, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-22 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"META":"Meta Platforms","MRNA":"Moderna, Inc.","NVDA":"英伟达"},"source_url":"https://www.fool.com/investing/2022/09/21/3-beaten-down-stocks-that-could-soar-51-to-70-from/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168375426","content_text":"KEY POINTSNvidia plans to launch several new chips that could improve its fortunes.Meta Platforms trades at a bargain price with a still-huge global user base for its social media platforms.Moderna hopes to market its COVID-19 vaccines in China and achieve success with its omicron boosters.Analysts remain very bullish about these former big winners.Down but not out. That old adage applies to many one-time high-flying growth stocks.Some stocks have taken it on the chin more than others. But some also could rebound more strongly, too. Here are three beaten-down stocks that could soar from 58% to 88%, according to Wall Street.1. Nvidia: New chips on the wayNvidia is a former rising star that's crashing and burning this year. Shares of the graphics chipmaker have plunged close to 55% so far in 2022. Macroeconomic issues and a cryptocurrency crash combined to pull the stock down.Analysts don't appear to be overly worried about any of these challenges, though. The average price target for the stock is nearly 51% higher than Nvidia's current share price.Nvidia CFO Colette Kress noted in the Q2 conference call that the company has several launches of next-generation superchip platforms on the way soon. Nvidia also recently launched an update to its NeMo Megatron artificial-intelligence framework that can increase the speed of training large language models by as much as 30%.Wall Street likely expects positive results from these launches. Analysts also recognize that Nvidia operates in a cyclical market. The current downturn won't last forever.2. Meta Platforms: A big-tech bargainFacebook-parent Meta Platforms hasn't received many \"likes\" from investors in 2022. The stock has fallen more than 50% year to date. Shareholders are worried about a slowing digital ad market, combined with Meta's massive and risky investment in the metaverse.However, Wall Street remains highly optimistic about Meta's prospects. The consensus 12-month price target for the stock reflects an upside potential of 53%.What do analysts like about Meta Platforms? Its valuation is no doubt high on the list. Meta's shares currently trade at only 12.2 times expected earnings. The company's social media platforms also still draw 2.88 billion active users on a daily basis and 3.65 billion on a monthly basis. Those numbers represent an audience that's still very attractive to advertisers.A rebound in digital-advertising growth would help Meta meet analysts' expectations. Over the longer term, the stock could be a monster winner if CEO Mark Zuckerberg's vision of the metaverse is fulfilled.3. Moderna: A potential bull in the China shopModerna is yet another company that's seen its high-flying ways of the past disappear. The vaccine stock has plummeted close to 50% year to date. It's now down more than 70% from the peak set in the summer of 2021.The biggest problem for Moderna is that COVID-19 cases are falling while the demand for vaccines seems to have plateaued. But analysts still think the best is yet to come for the messenger RNA (mRNA) pioneer. The average 12-month price target for Moderna is a whopping 70% higher than the current share price.Wall Street seems to believe that Moderna could have a big opportunity for its COVID-19 vaccines in China. The company is in discussions with the Chinese government about potentially marketing its vaccines in the country.Moderna could also regain momentum in North America and Europe with its boosters targeting the coronavirus omicron variant. It has recently won several authorizations for the new omicron booster.Over the longer term, Moderna hopes to expand beyond COVID-19. The company's pipeline includes three non-COVID candidates in late-stage testing -- experimental mRNA vaccines targeting flu, cytomegalovirus, and respiratory syncytial virus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104047283,"gmtCreate":1663879435925,"gmtModify":1663879439542,"authorId":3586678960137089,"author":{"id":3586678960137089,"authorId":3586678960137089,"name":"JeJu","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9919727553,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":707,"commentSize":0,"repostSize":0,"favoriteSize":2,"likeStatus":false,"favoriteStatus":false}}